共 50 条
- [1] Ipilimumab: An Anti-CTLA-4 Antibody for Metastatic Melanoma [J]. CLINICAL CANCER RESEARCH, 2011, 17 (22) : 6958 - 6962
- [3] Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy [J]. British Journal of Cancer, 2016, 114 : 1084 - 1089
- [6] Comment on ‘Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy’ [J]. British Journal of Cancer, 2017, 116 : e14 - e14
- [7] Ipilimumab.: Cancer immunotherapy, human anti-CTLA-4 MAb. [J]. DRUGS OF THE FUTURE, 2006, 31 (03) : 196 - 202
- [8] Reply to ‘Comment on ‘Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy’’ [J]. British Journal of Cancer, 2017, 116 : e15 - e15
- [10] Anti-CTLA-4 antibodies A major therapeutic advance in metastatic melanoma treatment [J]. M S-MEDECINE SCIENCES, 2011, 27 (10): : 850 - 858